After doctors told him he had just two to three years to live, a South Carolina father turned to Duke Health for a second ...

Survival in myeloma is clearly being prolonged,” says Mikhael. “Whereas historically, we saw a greater impact in younger ...

The bispecific T-cell engager talquetamab (Talvey) has some distinct adverse events (AEs) compared with drugs of the same class that target B-cell maturation antigen (BCMA) in mul ...

ImmunityBio, Inc. remains a Buy, with Anktiva’s regulatory and global expansion driving the investment thesis. Learn more ...

We are curing more cancers than we used to,” Cottrill said. “Recurrent cancers are more challenging to cure than cancers that ...

Sophia Wilson’s family feared they would need to travel to the US for treatment after raising £600,000 – but the ...

Finding an effective treatment for osteosarcoma, the most common type of bone cancer in children and young adults, has ...

This is key to preventing cervical cancer or catching it early. Cervical cancer can cause fertility issues, pain, kidney ...

Breast Cancer," Cleveland Clinic oncologist Tiffany Onger, MD, and host John Mangels continue their conversations on ...

Mesothelin-targeted CAR-NKT cells leveraged three recognition mechanisms, potentially limiting antigen escape and ...

TACTI-004 planned ~756 patients across >150 sites and enrolled 378 by February 2026, including squamous and nonsquamous NSCLC irrespective of PD-L1 status. Randomization compared eftilagimod alfa plus ...